|
|
|
|
| L-Glu | cerebral cortex projections
subthalamic nucleus (STN) ventroanterior and ventrolateral nuclei of the thalamus |
NMDA AMPA kainate mGluRI 1 mGluRII 2 mGluRII 3 mGluRIII 4 mGluRI 5 mGluRIII 6 mGluRIII 7 mGluRIII 8 |
| L-Asp |
|
|
|
|
| L-Gly | Gly receptor |
|
| g-aminobutyrric acid (GABA) | substantia nigra pars reticulata (SNpr), cerebellum (Purkinje's neurons), striatum, lateral globus pallidus (LGP), hippocampus, spinal cord | GABAA GABAB GABAC |
| taurine (a sulphur containing amino acid, is the most abundant intracellular amino acid in humans; conditionally essential amino acid for preterm neonate; in healthy individuals the diet is the usual source of taurine; although in the presence of vitamin B6 it is also synthesised from Met and Cys) | GABAA NMDAR Gly receptor |
|
|
|
|
| acetylcholine (ACh) | PNS :
|
N M1 M2 M3 M4 M5 |
|
|
|
|
| noradrenaline / norepinephrine (NE) | PNS : postganglionic neurons of orthosympathetic system
CNS : brainstem nuclei
|
... |
| dopamine (DA) / prolactin inhibiting factor (PIF) | Sommering's substantia nigra pars compacta (SNpc; area 9; => striatum),
mesolimbic tract neurons (area 10; => nucleus accumbens) nigrocortical tract neurons (area 10; => cortex) hypothalamopituitary tract neurons |
D1 D2 D3 D4 D5 |
|
|
|
|
5-hydroxytriptamine
(5-HT) / serotonin / enteramine
Plasma free Trp levels increase after meals containing large quantities of FFA, which can displace Trp from plasma proteins : anyway 5-HT release from neurons is regulated by limiting entry into secretory vesicles and intraneuronal 5-HT degradation. |
raphe nuclei, EC cells in Langerhans' islets, fundus and pylorus of stomach, jejunum, ileum, and colon | 5-HT1A 5-HT1B 5-HT1C / 2C 5-HT1D 5-HT1E 5-HT1F 5-HT2A / 2 / D 5-HT2B / 2F 5-HT3 / M 5-HT4 5-HT5A 5-HT5B 5-HT6 5-HT7 |
|
|
|
|
histamine /
b-aminoethylimidazole
![]() |
mast cells |
H1 H2 H3 H4 |
|
|
name |
|
|
| acylethanolamides (AEs)ref | palmitylethanolamide (PEA) | astrocytes | CB2 |
| anandamide (arachidonylethanolamide (AEA))
arachidonic acid
+ PA |
immature dendritic cells, neurons, astrocytes | CB1 |
|
| homo-g-linolenylethanolamide (HEA) | astrocytes | CB1 |
|
| docosatetraenylethanolamide (DEA) | astrocytes | CB1 |
|
| oleylethanolamide (OEA) | small intestine, astrocytes | PPAR-a |
|
| myristylethanolamide | |||
| palmitelaidylethanolamide | |||
| palmitoleylethanolamide | |||
| N-palmitoylethanolamine (PalEtn) | immature dendritic cells, neurons | ||
| 2-arachidonoylglycerol amide (2-AG) | immature dendritic cells, neurons | CB2 |
|
| oleamide / sleep-inducing factor |
| morphine |
neuroblastoma cells and pancreatic carcinoma cells | m3 |

|
|
|
|
advanced glycation
|
RAGE galectin-3 macrophage scavenger receptor class A types I and II (SR-A) CD36 scavenger receptor class B type I (SR-BI) LOX-1 FEEL-1 FEEL-2 |
|
|
|
|||
| lysophospholipids (LPs) | lysophosphatidic
acid (LPA) : 3 different stimulus-coupled cellular pathways for rapid
synthesis and release of this mediator are known.
|
EDG2 EDG4 EDG7 |
||
| =sphingomyelinase=> ? =ceramidase=>
sphingosine =sphingosine kinase |
EDG1 EDG3 EDG5 EDG8 |
|||
1-O-alkyl-2-acyl-sn-glyceryl-3-phosphorylcholine
=PL-A2
Inactivated by PAF acetylhydrolase. |
PAFR |
|||
| lysophosphatidylcholine (LPC) | G2A / LPC1 |
|||
| sphingosylphosphoryl choline (SPC) | GPR68 / OGR-1 / SPC1 |
|||
| psychosine / galactosylsphingosine | GPR65 / TDAG8 |
|||
| prostanoids (a subscript is used to indicate the number of double bonds in the fatty acid) | prostaglandins (analogs of the unnatural compound prostanoic acid) | PGG2 | ||
| PGH2 | TP |
|||
| PGA2 | ||||
| PGD2 | DP1 DP2 / CRTH2 / GPR44 PPAR-g |
|||
| 9a,11b-PGF2 | ||||
| PGD-M | ||||
| 15-deoxy-D12,14-PGD2 (15dPGD2) | ||||
| PGE1 | IP |
|||
PGE2
![]() |
EP1 EP2 EP3 EP4 |
|||
| PGE3 | ||||
| PGE-M | ||||
| PGF2a | FP |
|||
| PGF-M | ||||
| PGI2 / prostacyclin (PC) (have half-lives on the order to seconds to a few minutes) | IP PPAR-g |
|||
| 6-keto-PGF1a | ||||
| 2,3-dinor-6-keto-PGF1a | ||||
| PGJ2 | PPAR-g |
|||
| 5-deoxy-D12,14-PGJ2 (15dPGJ2) | PPAR-g |
|||
leukotrienes. LTC4,
LTD4 and LTE4 are collectivelly referred as cysteinyl
leukotrienes or slow-reacting substance of anaphylaxis (SRS-A).
5,8,11,14,17-eicosapentaenoic acid (EPA) |
LTA4 | |||
| LTB4 (exits cell via ?) | B-LT1 / P2Y7 B-LT2 PPAR-a PPAR-g (intranuclear signaling for negative feedback loop) |
|||
| LTC4 (exits cell via MRP1 and ABCC1 / MDR-associated protein type 2 (MRP2)) | cysLT1 cysLT2 |
|||
| LTD4 (generated extracellularly) | cysLT1 cysLT2 |
|||
| LTE4 (generated extracellularly) | cysLT1 cysLT2 |
|||
| thromboxans (analogs of the unnatural compound thrombanoic acid; have half-lives on the order to seconds to a few minutes) | TXA1 | TXA1R |
||
| TXA2 | TP |
|||
| TXB2 | ||||
| 2,3-dinor-TXB2 | ||||
| lipoxins | LXA4 | FPR-like (FPRL) 1 / ALXR AHR |
||
| aspirin-triggered
lipoxin (ATL) / 15(R)-epi-LXA4 (due to acetylation
of COX-2 by acetylsalicylic
acid |
FPR-like (FPRL) 1 / ALXR |
|||
| LXB4 | ||||
| 5-oxo-ETE | ||||
| hydroxy-ETE (HETE) | ||||
| epoxy (EET) | ||||
|
|
|
|
|
|
| Hematopoietins (4-helix bundles) | erythropoietin (EPO) / hematopoietin / hemopoietin; monomer or dimer of a 165 amino-acid sequence glycoprotein | interstitial cells which are localized around the proximal renal tubule (90%), hepatocytes (10%; higher in fetal liver). Paracrine and autocrine functions in endometrial cells in the secretory > proliferative phase, placenta, astrocytes, Sertoli and peritubular myoid cells, and capillary endothelium | EPOR |
|
| interleukin 2 (IL-2) / BF / EDF / KHF / LMF / LCM factor / LPF / MAF-C I / PFC-EA / SCIF / T-cell growth factor (TCGF) / TCPA / TDF / TGP-3 / TMF / TRF-3 / TSF ; monomer | T lymphocytes | IL-2R |
||
| IL-3 / multicolony stimulating factor (multi-CSF); monomer | all classes of T and NK2 lymphocytes, thymic epithelial cells (TECs),
mast
cells |
IL-3R |
||
| IL-4 / BCGF-1 / TCGF-2 / B lymphocyte stimulatory factor 1 (BSF-1); monomer : the one interchain disulfide bond is required for biologic activity | Th2 lymphocytes |
IL-4R |
||
| IL-5 / BCGF-2 / Eo-CSF ; homodimer | Th2 lymphocytes |
IL-5R |
||
| IL-6 / IFN-b2 / B lymphocyte stimulatory factor 2 (BSF-2) / BCDF; monomer | white adipose tissue (30% of plasma IL-6 under basal conditionsref;
visceral > subcutaneousref),
T lymphocytes, macrophages, endothelial cells (stimulated by CRP |
IL-6R |
||
| IL-7 / TCGF-b; monomer or dimer | bone marrow, TECs | IL-7R |
||
| thymic stromal lymphopoietin (TSLP) | ||||
| IL-9 / TCGF-3; monomer | T lymphocytes | IL-9R |
||
| IL-11; monomer | stromal fibroblasts in bone marrow | IL-11R |
||
| IL-13 / P600; monomer | Th2 lymphocytes |
IL-13R |
||
| granulocyte colony stimulating factor (G-CSF) / CSF-3 ; monomer or dimer | fibroblasts, monocytes, macrophages, stimulated endothelial cells, TECs, stromal cells | G-CSFR |
||
| macrophage colony stimulating factor (M-CSF) / CSF-1 | fibroblasts, stimulated endothelial cells, bone-marrow stroma, monocytes, macrophages, T lymphocytes, B lymphocytes, epithelial cells (including TECs) | M-CSFR / CD115 |
||
| IL-15 / IL-T; monomer (48 aa-long signal sequence isoform localizes in plasma membrane or is secreted; 21 aa-long signal sequence isoform is found within the cytoplasm or nucleus | activated monocytes and macrophages, dendritic cells, skeletal muscle, kidney, lung, heart, and placenta | IL-15R |
||
| granulocyte and macrophage colony stimulating factor (GM-CSF) / CSF-2 / BPA ; monomer or dimer | monocytes, macrophages, all classes of T and NK lymphocytes, epithelial cells (including respiratory epithelial cells, stimulated endothelial cells and TECs), fibroblasts, eosinophils | GM-CSFR soluble GM-CSFR a subunit (sGMRa) arises through alternative splicing or ectodomain shedding by MMPs |
||
| oncostatin M (OSM / OM); monomer | T lymphocytes, activated monocytes and macrophages, bone marrow stromal cells, some lines of mammary carcinoma and myeloma | OSMR LIFR |
||
| leukemia inhibiting factor (LIF); monomer | bone marrow stromal cells, fibroblasts, osteoblasts, TECs, activated T lymphocytes | LIFR |
||
| ciliary neurotrophic factor (CNTF) | CNTFR |
|||
| neurotrophin 1 (NTF-1 / NT-1) / B-cell stimulatory factor-3 | ||||
| cardiotrophin-1 | ||||
| Interferons (IFNs) => viral interference within 4÷6 hrs, induction of CXCL10 / IP-10 | type I interferons (=> IRF => ISRE => IFN-stimulated genes (ISGs)) | IFN-a ; 18 paralogous intron-less genes on 9p : 6 of them are pseudogenes; monomer; high diffusibility, induces up-regulation of MHC class I and b2-microglobulin | most cell types : leukocytes (including B lymphocytes and macrophages) | IFNAR1 / CD118 IFNAR2 |
| IFN-b ; b1 and b3 (b2 is now renamed IL-6); low diffusibility, induces up-regulation of MHC class I and b2-microglobulin ; monomer | most cell types : fibroblasts and some epithelia | IFNAR1 / CD118 IFNAR2 |
||
| IFN-k | unstimulated keratinocytes, peripheral blood monocytes, and monocyte-derived dendritic cells (up-regulated by type I and type II IFNs) | IFNAR1 / CD118 IFNAR2 |
||
| IFN-l2 / IL-28A | IL-28 and IL-29
R |
|||
| IFN-l3 / IL-28B | ||||
| IFN-l1 / IL-29 | ||||
| IFN-w1 | IFNAR1 / CD118 IFNAR2 |
|||
| type II interferon | IFN-g / macrophage-activating factor (MAF); homodimer ; 12q; induces temporary expression of MHC class II molecules on fibroblasts and other cell types and up-regulation of MHC class I and b2-microglobulin | Th1
lymphocytes |
IFNGR1 / CD119 IFNGR2 |
|
| immunoglobulin superfamily (IgSF) | B7.1 / CD80 ; dimer | APCs | CD28 CD152 / CTLA-4 |
|
| B7.2 / B70 / CD86 | APCs | CD28 CD152 / CTLA-4 |
||
| TNF (ligand) superfamily (TNFSF) | TNFSF1 / TNF-b/ lymphotoxin (LT) -a (LT-a) ; a3 homotrimer or a2b1 heterotrimer with LT-b, which anchors it to the cell surface | activated monocytes and macrophages, activated T lymphocytes, B lymphocytes and NK cells and a wide variety of other cells | CD120a / p55TNFRI CD120b / p75TNFRII |
|
| TNFSF2 / TNF-a / cachectin ; soluble homotrimer lymphokine capable of causing in vivo hemorrhagic necrosis of certain tumor cells, but not affecting normal cells; it has been used as an experimental anticancer agent. It can also induce shock when bacterial endotoxins cause its release | macrophages, NK cells, B cells, T cells, mast
cells |
CD120a / p55TNFRI CD120b / p75TNFRII |
||
| TNFSF3 / LT-b ; a and b isoforms; transmembrane, b3 homotrimer or a1b2 heterotrimer with TNF-b / LT-a, anchoring it to the cell surface | T lymphocytes, B lymphocytes (?) | LTbR HVEM |
||
| TNFSF4 / OX40L / CD134L / gp34 | activated CD4+ T lymphocytes | OX40 / CD134 |
||
| TNFSF5 / CD154 / 40L / TRAP ; homotrimer | T lymphocytes, mast cells | |||